NCT04121130 is a NA clinical trial of F-ESWT Group in Myofascial Pain Syndrome, sponsored by Fundación Garcia Cugat.

Who is sponsoring NCT04121130?

NCT04121130 is sponsored by Fundación Garcia Cugat.

What drugs are being tested in NCT04121130?

Interventions in NCT04121130: F-ESWT Group, sham F-ESWT.

What condition does NCT04121130 study?

NCT04121130 studies Myofascial Pain Syndrome.

Is NCT04121130 still recruiting?

NCT04121130 is currently completed. Last updated 21 July 2021.

Last reviewed 2021-07-21 · How we verify

NCT04121130

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Shockwave Effectiveness in Myofascial Pain of the Upper Trapezius Muscle

Completed NA Last updated 21 July 2021

What this trial tests

NA trial testing F-ESWT Group in Myofascial Pain Syndrome in 60 participants. Completed in 15 November 2019.

Timeline

27 February 2019

Primary endpoint
1 November 2019

15 November 2019

Quick facts

Lead sponsor	Fundación Garcia Cugat
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	27 February 2019
Primary completion	1 November 2019
Estimated completion	15 November 2019
Sites	1 location across Spain

Drugs / interventions tested

F-ESWT Group
sham F-ESWT

Conditions studied

Myofascial Pain Syndrome — all drugs for Myofascial Pain Syndrome →

Sponsor

Fundación Garcia Cugat

Who can join

18 and older, any sex, with Myofascial Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Focused shockwaves are generated electrically, either within the applicator (electrohydraulic technique), or externally to it in the focal zone (electromagnetic or piezoelectric techniques), and then propagate to a designated focal point in order to treat it. Most research in shockwave therapy has focused on understanding the mechanism which results in the establishment of a mechano-sensitive feedback loop between the acoustic impulse and the stimulated cells, and involves specific transduction pathways and gene expression. Taking as valid the current physiopathological hypothesis of myofascial pain (MPS) and considering the mechanotransduction effect of ESWT in other diseases, it could be posited that ESWT in MPS may increase perfusion, promote angiogenesis and alter the pain signaling in ischaemic tissues caused by the influx of calcium. On the other hand, recent articles have demonstrated that free nerve endings degenerate after the application of ESWT, and that ESWT produces a transient dysfunction of nerve excitability at the neuromuscular junction, by bringing about the degeneration of AChR. Finally, following a pure mechanistic approach, shockwaves might be able to break-up the Actine-myosin links, as they are propagating perpendicularly to the sarcomere contractions. Study Hypothesis: To obtain pain relief and improvement in functional and quality of life scales, by performing 3 ESWT sessions, 1 per week (0,10 mJ/mm2; 2000 impulses; 5 Hz) in the most painful tender and/or trigger points of the upper trapezius muscle. Primary objective: To analyze the effectiveness of Focused Shockwave Treatment in myofascial pain of the upper trapezius muscle.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Myofascial Pain Syndrome

Currently open trials in the same condition.

NCT07511751 — COMPARISON OF THREE TREATMENT MODALITIES İN MYOFASCIAL PAIN SYNDROME · NA · recruiting
NCT07045324 — Effect of Vagus Nerve Stimulation on Trapezius Trigger Point · NA · active not recruiting

Other Fundación Garcia Cugat trials

Trials by the same sponsor.

NCT04123782 — Focused Shockwave Treatment in the Recovery Process of Acute Muscle Injuries in Soccer Players · NA · completed
NCT04120662 — Effectiveness of Shockwave Treatment for Proximal Fifth Metatarsal Stress Fracture in Soccer Players · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04121130 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fundación Garcia Cugat
Last refreshed: 21 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04121130.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing